Player FM - Internet Radio Done Right
Checked 11d ago
Lagt til nine år siden
Innhold levert av The Immune-Mediated Inflammatory Disease Forum. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av The Immune-Mediated Inflammatory Disease Forum eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!
Gå frakoblet med Player FM -appen!
Podcaster verdt å lytte til
SPONSET
<
<div class="span index">1</div> <span><a class="" data-remote="true" data-type="html" href="/series/peak-travel">Peak Travel</a></span>
Travel can do amazing things: broaden horizons, build relationships, and rejuvenate the soul. But often, those experiences come at a cost. This is Peak Travel, a new podcast from WHYY about how travel shapes communities in hot-spots around the world. We’ll share the wonder that comes with exploring new places, as well as the harm that our worst travel habits can cause. And we’ll try to figure out how we can do it better. Each episode transports you to a new destination. You’ll meet the people who call that place home, hear their stories, and come to understand how tourism has changed their everyday lives. Supported by rich, on-location sound from around the world, Peak Travel unpacks the $1.9 trillion travel industry and its impact on people and the planet.
The IMID Forum
Merk alt (u)spilt...
Manage series 1044916
Innhold levert av The Immune-Mediated Inflammatory Disease Forum. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av The Immune-Mediated Inflammatory Disease Forum eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
…
continue reading
338 episoder
Merk alt (u)spilt...
Manage series 1044916
Innhold levert av The Immune-Mediated Inflammatory Disease Forum. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av The Immune-Mediated Inflammatory Disease Forum eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
…
continue reading
338 episoder
Alle episoder
×T
The IMID Forum
1 Discussing RA: Insights into sustained DMARD-free remission and barriers to CAR T-cell therapy 11:18
11:18
Spill senere
Spill senere
Lister
Lik
Likt
11:18Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest updates in RA. In this episode, Professor McInnes discusses two papers: subgroups of patients with early RA with or without bDMARD who reached sustained DMARD-free remission and barriers to the widespread adoption of CAR T-cell therapy in rheumatic diseases.…
T
The IMID Forum
1 Discussing AxSpA Podcast: Efficacy and Safety of Upadacitinib 18:42
18:42
Spill senere
Spill senere
Lister
Lik
Likt
18:42Join us for the latest axSpA podcast brought to you by the Immune-Mediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar, and Xenfon Baraliakos to discuss a recent study on the efficacy and safety of upadacitinib in patient with ankylosing spondylitis.…
T
The IMID Forum
1 Discussing RA: Insights into Filgotinib and Tofacitinib in RA 24:13
24:13
Spill senere
Spill senere
Lister
Lik
Likt
24:13Join Professor Iain McInnes and Professor Rieke Alten for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest updates in RA. In this episode, they discuss two papers which discuss the efficacy and safety of filgotinib, and lymphocyte count and infection risk associated with tofacitinib in rheumatoid arthritis.…
ACR 2024 Review Podcast by The Immune-Mediated Inflammatory Disease Forum
T
The IMID Forum
1 PsA Podcast: DISCOVER-2 and BE OPTIMAL/BE COMPLETE post-hoc analyses 30:53
30:53
Spill senere
Spill senere
Lister
Lik
Likt
30:53Join Professors Peter Nash and Philip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered a post hoc analysis examining the rapid and sustained efficacy of bimekizumab in PsA patients across different subgroups, focusing on improvements in pain, fatigue, and physical function over 16 weeks. The conversation also covered a long-term analysis of guselkumab assessing the durability of clinical improvements in joint and skin symptoms in PsA patients over a 2-year period.…
T
The IMID Forum
1 Discussing RA: Insights into Filgotinib and Tofacitinib in RA 19:16
19:16
Spill senere
Spill senere
Lister
Lik
Likt
19:16Join Professor Iain McInnes and Professor Johannes Bijlsma for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest information and data in RA. In this episode, they discuss two papers which discuss the efficacy and safety of filgotinib, and lymphocyte count and infection risk associated with tofacitinib in rheumatoid arthritis.…
T
The IMID Forum
1 Webinar Highlights Podcast: CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases 26:39
26:39
Spill senere
Spill senere
Lister
Lik
Likt
26:39Webinar Highlights Podcast: Join Professor Iain McInnes and Professor Georg Schett as they discuss the recent webinar hosted on the IMID Forum: “CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases”. Listen to them discuss key highlights from the webinar including the development of CAR T-cell therapy, the application of CAR T to autoimmune diseases, and the potential risks and reservations associated with this therapeutic approach.…
ACR 2024 Highlights: Day 3 by The Immune-Mediated Inflammatory Disease Forum
ACR 2024 Highlights: Day 2 by The Immune-Mediated Inflammatory Disease Forum
ACR 2024 Highlights: Day 1 by The Immune-Mediated Inflammatory Disease Forum
T
The IMID Forum
ACR 2024: Preview Podcast by The Immune-Mediated Inflammatory Disease Forum
T
The IMID Forum
1 AxSpA Podcast: Efficacy and Safety of IV secukinumab 23:30
23:30
Spill senere
Spill senere
Lister
Lik
Likt
23:30Join us for the latest axSpA podcast brought to you by the Immune-Mediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, and Atul Deodhar to discuss a recent study on the efficacy and safety of IV secukinumab in patient with active axSpA.
T
The IMID Forum
1 Discussing RA: Navigating JAKis, TNFis, and the quest for optimal RA therapy 22:03
22:03
Spill senere
Spill senere
Lister
Lik
Likt
22:03Join Professor Iain McInnes and Professor Leonard Calabrese for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest information and data in RA. In this episode, they discuss two papers which investigate the efficacy and safety of JAK inhibitors and TNF inhibitors for rheumatoid arthritis, while also uncovering the best treatment strategies for difficult-to-treat RA.…
T
The IMID Forum
1 Author Interview: Derin Karacabeyli, 2024 33:27
33:27
Spill senere
Spill senere
Lister
Lik
Likt
33:27Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Derin Karacabeyli of Arthritis Research Canada, a rheumatologist and resident in the University of British Columbia Clinician Investigator Program, as they discuss his recent paper ‘Mortality and major adverse cardiovascular events after glucagon-like peptide-1 receptor agonist initiation in patients with immune-mediated inflammatory diseases and type 2 diabetes: A population-based study’, published in PLoS One on 08th August 2024.…
T
The IMID Forum
1 Webinar Highlights Podcast 2: Evolving Therapeutic Strategies for Psoriatic Diseases 32:56
32:56
Spill senere
Spill senere
Lister
Lik
Likt
32:56Webinar Highlights Podcast: Join Professor Christopher Ritchlin, and Professor Philip Mease as they discuss the recent webinar hosted on the IMID Forum ‘Evolving Therapeutic Strategies for Psoriatic Diseases: Not all IL-23s are Created Similar - Part 2’. Watch them discuss key highlights from the webinar including the burden of PsA and PsO, the similarities and differences in pathology in skin and joints across psoriatic arthritis, and a special focus on IL-23, and its clinical data and impact across different tissue domains.…
Velkommen til Player FM!
Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.